Potently neutralizing and protective human antibodies against SARS-CoV-2
…, A Chandrashekar, NB Mercado, JJ Steinhardt, K Ren… - Nature, 2020 - nature.com
The ongoing pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health …
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
…, S Diallo, DJ Flores, EJ Kelly, K Ren… - Science translational …, 2022 - science.org
Despite the success of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines, there remains a need for more prevention and treatment options for individuals …
vaccines, there remains a need for more prevention and treatment options for individuals …
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
…, B Guarino, MA Schmid, K Rosenthal, K Ren… - Nature …, 2022 - nature.com
Omicron variant strains encode large numbers of changes in the spike protein compared to
historical SARS-CoV-2 isolates. Although in vitro studies have suggested that several …
historical SARS-CoV-2 isolates. Although in vitro studies have suggested that several …
Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue
…, MP McMurry, GA Wiebke, KJ Felten, K Ren… - Metabolism, 1997 - Elsevier
Plasma estradiol has been suggested to suppress adipose tissue lipoprotein lipase (LPL)
activity in women. The present study explores the regulation of LPL by sex steroids in …
activity in women. The present study explores the regulation of LPL by sex steroids in …
DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
…, JD Chu, G Villafana, K Rosenthal, K Ren… - Nature …, 2022 - nature.com
Monoclonal antibody therapy has played an important role against SARS-CoV-2. Strategies
to deliver functional, antibody-based therapeutics with improved in vivo durability are …
to deliver functional, antibody-based therapeutics with improved in vivo durability are …
Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals
…, NM Kafai, ES Winkler, JM Fox, JJ Steinhardt, K Ren… - BioRxiv, 2020 - biorxiv.org
The COVID-19 pandemic is a major threat to global health for which there are only limited
medical countermeasures, and we lack a thorough understanding of mechanisms of humoral …
medical countermeasures, and we lack a thorough understanding of mechanisms of humoral …
Development of a parallel reaction monitoring mass spectrometry assay for the detection of SARS-CoV-2 spike glycoprotein and nucleoprotein
…, S Rajan, W Dall'Acqua, L Clarke, K Ren… - Analytical …, 2020 - ACS Publications
There is an urgent need for robust and high-throughput methods for SARS-CoV-2 detection
in suspected patient samples to facilitate disease management, surveillance, and control. …
in suspected patient samples to facilitate disease management, surveillance, and control. …
Increased lipase inhibition in uremia: identification of pre-β-HDL as a major inhibitor in normal and uremic plasma
AK Cheung, CJ Parker, K Ren, PH Iverius - Kidney international, 1996 - Elsevier
Increased lipase inhibition in uremia: Identification of pre-β-HDL as a major inhibitor in normal
and uremic plasma. The hypertriglyceridemia commonly observed in uremia has been …
and uremic plasma. The hypertriglyceridemia commonly observed in uremia has been …
AZD7442 demonstrates prophylactic and therapeutic efficacy in non-human primates and extended half-life in humans
…, A Aksyuk, S Diallo, DJ Flores, EJ Kelly, K Ren… - Medrxiv, 2021 - medrxiv.org
Despite the success of SARS-CoV-2 vaccines, there remains a need for more prevention
and treatment options for individuals remaining at risk of COVID-19. Monoclonal antibodies (…
and treatment options for individuals remaining at risk of COVID-19. Monoclonal antibodies (…
Immunization with low doses of recombinant postfusion or prefusion respiratory syncytial virus F primes for vaccine-enhanced disease in the cotton rat model …
…, K Nacel, L Hostetler, L Cheng, K Ren… - Journal of …, 2017 - Am Soc Microbiol
Respiratory syncytial virus (RSV) infection of children previously immunized with a nonlive,
formalin-inactivated (FI)-RSV vaccine has been associated with serious enhanced …
formalin-inactivated (FI)-RSV vaccine has been associated with serious enhanced …